Add Yahoo as a preferred source to see more of our stories on Google. The development of gene-editing technology has led to many ethical questions. PhonlamaiPhoto/iStock via Getty Images Plus With ...
A multidisciplinary committee of experts studied the scientific underpinnings of human gene-editing technologies, their potential use in biomedical research and medicine -- including human germline ...
The Case Western Reserve University Science and Human Rights Coalition will host Andrea Waksmunski, a PhD candidate in the Department of Genetics and Genome Sciences, for a talk titled “Ethics of ...
Shai Carmi is in the Braun School of Public Health and Community Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel. Read the paper: Heritable polygenic editing as a potential ...
A major biomedical breakthrough won the 2020 Nobel Prize for CRISPR technology for genome editing, which can potentially save the lives of many people afflicted with genetic diseases. Currently, there ...
With their primary goal to advance scientific knowledge, most scientists are not trained or incentivized to think through the societal implications of the technologies they are developing. Even in ...
Discover how prime editing is redefining the future of medicine by offering highly precise, safe, and versatile DNA corrections, bringing hope for more effective treatments for genetic diseases while ...
Vence L. Bonham Jr., Acting Deputy Director at the National Human Genome Research Institute (NHGRI) and an investigator in the National Human Genome Research Institute’s (NHGRI) Division of Intramural ...
AZoLifeSciences on MSN
Emerging Genome Editing Technologies in Precision Biology
Genome editing is no longer a futuristic concept — scientists are already rewriting the genetic material of living organisms ...
Megan Molteni reports on discoveries from the frontiers of genomic medicine, neuroscience, and reproductive tech. She joined STAT in 2021 after covering health and science at WIRED. You can reach ...
Morning Overview on MSN
Gene editing advances raise real prospects for future DNA upgrades
The U.S. Food and Drug Administration approved the first cell-based gene therapies for sickle cell disease, including the first-ever treatment built on CRISPR/Cas9 technology. That decision moved gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results